National Healthcare Properties Inc

Análisis de la acción National Healthcare Properties Inc (NHP)

$16.060

-0.419 (-2.61%)Al cierre

Loading chart…
High
16.660
Open
16.490
VWAP
16.25
Vol
276.91K
Mkt Cap
Low
16.020
Amount
4.50M
EV/EBITDA, TTM
15.27

National Healthcare Properties, Inc. is a real estate investment trust, which is focused on acquiring, owning and managing a diversified portfolio of healthcare real estate assets focused on senior housing operating properties (SHOP) and outpatient medical facilities (OMF) in the United States. It has two operating and reportable segments: SHOP and OMF. In the SHOP segment, the Company invests in senior housing properties. In the OMF segment, it owns, manages and leases single and multi-tenant OMFs. It owns over 167 properties and a land parcel located in 29 states, consisting of 37 senior housing communities, with 3,615 units, in its SHOP segment and 130 outpatient medical facilities, with approximately 3.7 million square feet in OMF segment. Its properties include Surgery Center of Temple - Temple, TX, Greenville Health System - Greenville, SC; Stockbridge Family Medical - Stockbridge, GA; Berwyn Medical Center - Berwyn, IL; Countryside Medical Arts - Safety Harbor, FL, and others.

nhpreit.com

AI analysis of National Healthcare Properties Inc (NHP)

buy

National Healthcare Properties, Inc. is a good buy right now due to its recent positive performance indicators and growth potential. The stock has shown a year-to-date increase of 33.83%, and analysts have set a price target as high as $21, suggesting a potential upside of 30.5% from the current price. Additionally, the company reported a significant increase in funds from operations (FFO) from $5.35 million to $11.95 million year-over-year, indicating improved financial health. However, the main risk is the company's high debt-to-equity ratio of 34.77%, which could impact financial stability if not managed carefully.

Métricas de valoración

The current forward P/E ratio for National Healthcare Properties Inc (NHP) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E
Current P/E
0.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
15.96
Current EV/EBITDA
15.27
Sobrevalorada
18.61
Infravalorada
13.31

Forward P/S

Fair
5Y Average P/S
2.56
Current P/S
2.83
Sobrevalorada
3.01
Infravalorada
2.11

Whales holding NHP

Z

Zimmer Partners, LP

+ HoldingNHP

+1.59%

3M Return

Cronología de eventos

2026-08-07 (ET)

17:00:00

National Healthcare Properties Files Mixed Securities Shelf

2026-05-04 (ET)

06:20:00

National Healthcare Properties Sells 86 Outpatient Facilities for Approximately $528M

2026-04-27 (ET)

11:20:00

X-energy and Yesway Show Strong Debut Performance

2026-04-22 (ET)

11:10:00

National Healthcare Properties Prices IPO at $12

Noticias

NHP FAQ — answered by Alphio AI

National Healthcare Properties, Inc. is a real estate investment trust, which is focused on acquiring, owning and managing a diversified portfolio of healthcare real estate assets focused on senior housing operating properties (SHOP) and outpatient medical facilities (OMF) in the United States. It has two operating and reportable segments: SHOP and OMF. In the SHOP segment, the Company invests in senior housing properties. In the OMF segment, it owns, manages and leases single and multi-tenant OMFs. It owns over 167 properties and a land parcel located in 29 states, consisting of 37 senior housing communities, with 3,615 units, in its SHOP segment and 130 outpatient medical facilities, with approximately 3.7 million square feet in OMF segment. Its properties include Surgery Center of Temple - Temple, TX, Greenville Health System - Greenville, SC; Stockbridge Family Medical - Stockbridge, GA; Berwyn Medical Center - Berwyn, IL; Countryside Medical Arts - Safety Harbor, FL, and others. It operates in the Real Estate sector.

National Healthcare Properties, Inc. is a good buy right now due to its recent positive performance indicators and growth potential. The stock has shown a year-to-date increase of 33.83%, and analysts have set a price target as high as $21, suggesting a potential upside of 30.5% from the current price. Additionally, the company reported a significant increase in funds from operations (FFO) from $5.35 million to $11.95 million year-over-year, indicating improved financial health. However, the main risk is the company's high debt-to-equity ratio of 34.77%, which could impact financial stability if not managed carefully.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis